The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios

George Ng, Constance Wang
doi: https://doi.org/10.1101/2020.04.21.20074070

Article Information

doi 
https://doi.org/10.1101/2020.04.21.20074070
History 
  • April 26, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. George Ng, PhD1,2,* and
  2. Constance Wang, PhD1
  1. 1University of California, Berkeley, School of Public Health
  2. 2University of California, Berkeley, College of Engineering
  1. ↵*Corresponding author: George Ng, PhD, University of California, Berkeley, School of Public Health, 2121 Berkeley Way West Berkeley, CA 94720-1760, georgeng{at}berkeley.edu, +1.415.830.1425
Back to top
Posted April 26, 2020.
Download PDF
Data/Code
Email
The proportion testing positive for SARS-COV-2 among the tested population in the U.S.: Benefits of the positive test ratio under scaled testing scenarios
George Ng, Constance Wang
medRxiv 2020.04.21.20074070; doi: https://doi.org/10.1101/2020.04.21.20074070
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area